Principal Financial Group Inc Aytu Biopharma, Inc Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021
BUY
$6.23 - $9.88 $20,154 - $31,961
3,235 Added 8.23%
42,551 $323,000
Q4 2020

Feb 08, 2021
BUY
$5.98 - $13.5 $235,109 - $530,766
39,316 New
39,316 $235,000

Others Institutions Holding AYTU

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AYTU BIOPHARMA, INC

AYTU Quotes by TradingView
  • Ticker AYTU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 62,432,700
  • Market Cap $88.7M
  • Description
  • Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...
More about AYTU
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email